Faezzah Baharom
About Faezzah Baharom
Faezzah Baharom is a Postdoctoral Scientist at the National Institutes of Health, specializing in the development of personalized cancer vaccines that integrate peptide neoantigens with TLR7/8 agonists. She has a PhD in Medical Science from Karolinska Institutet and has previously worked as a Postdoctoral Researcher at the same institution.
Work at National Institutes of Health
Faezzah Baharom has been employed as a Postdoctoral Scientist at the National Institutes of Health (NIH) since 2017. Her work focuses on the development of personalized cancer vaccines, utilizing a novel platform that integrates peptide neoantigens with TLR7/8 agonists. This research aims to enhance the effectiveness of cancer immunotherapy by tailoring vaccines to individual patient profiles. The NIH is a leading biomedical research institution, providing an environment for advanced scientific inquiry and collaboration.
Education and Expertise
Faezzah Baharom holds a Bachelor of Science (B.Sc.) in Biological Sciences from Nanyang Technological University, completed from 2008 to 2011. She further pursued her education at Karolinska Institutet, where she obtained a Doctor of Philosophy (PhD) in Medical Science from 2012 to 2016. Additionally, she studied Entrepreneurship at the Stockholm School of Entrepreneurship in 2013. Her academic background equips her with a strong foundation in biological sciences and medical research, particularly in cancer immunology.
Background
Faezzah Baharom began her academic journey at Raffles Junior College from 2006 to 2007. She then attended Linköpings universitet for a brief period in 2011. Her research career includes a role as a Doctoral Student at Karolinska Institutet from 2012 to 2016, where she focused on understanding the innate mechanisms that drive anti-tumor CD8 T cells upon vaccination. This experience laid the groundwork for her subsequent work at the NIH.
Previous Experience at Karolinska Institutet
Before her current position at the NIH, Faezzah Baharom worked at Karolinska Institutet as a Postdoctoral Researcher for five months in 2016. During her time there, she contributed to research initiatives that aligned with her interests in cancer immunology. Her earlier role as a Doctoral Student at the same institution from 2012 to 2016 further solidified her expertise in the field.